Delivery Order SPE2DB22D3401-SPE2DB25FT6HP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Letrozole 2.5 mg tablets (90-count units) on September 11, 2025, with a ceiling value of $1,448.81 and an ultimate completion date of September 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units at a firm fixed price of $1,648.08. This non-competitive, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order is scheduled for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units, with a contract ceiling value of $2,110.12. This is a firm fixed price delivery order with an ultimate completion date of September 16, 2025, and was awarded without a set-aside designation through competitive procurement. The place of performance is located in Conshohocken, Pennsylvania, which serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Letrozole 2.5 mg tablets (90-count units) valued at $1,081.74. This firm fixed-price delivery order, with an ultimate completion date of July 15, 2025, represents a pediatric continuation under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The award involved no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units, with a contract ceiling value of $2,163.36. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 14, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating the award was made...
- The Defense Logistics Agency (DLA) awarded a $1,145.15 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 30. The contract, which is a firm fixed price delivery order with no set-aside designation, is scheduled for completion by July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a competitive procurement action and reflects AmerisourceBergen's role as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units, valued at $1,403.88. This firm fixed price delivery order, which is not set-aside and was competitively awarded, is set for ultimate completion on July 29, 2025. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government, with performance occurring at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Letrozole 2.5 mg tablets (30-count units) with a ceiling value of $1,444.11. The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 3, 2025, and was awarded on a competitive basis without set-aside designation. AmerisourceBergen's corporate office, located in Conshohocken, Pennsylvania—which serves as both the vendor's...
- The Defense Logistics Agency awarded a $3,172.86 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Letrozole 2.5 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child delivery order under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units at a firm fixed price of $1,271.50. This is a non-set-aside competitively awarded contract with an ultimate completion date of August 14, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a single transaction within AmerisourceBergen's...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT6HPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Letrozole 2.5 mg tablets in a 90-count package, with a ceiling value of $3,217.18. This is a firm fixed-price, competitive delivery order with no set-aside designation and an ultimate completion date of September 22, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through this comprehensive global pharmaceutical support vehicle. The parent IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs, including specialty medications, brand-name and generic drugs, vaccines, and other medical commodities across multiple therapeutic domains. This delivery order for Letrozole, a hormone therapy medication, exemplifies the company's role in supplying essential pharmaceuticals to the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 9/19/25 |